GlassScriptPhysician profile
Aimee J Swartz
NPI 1093913972
$2,513.61
in general payments reported to CMS, 2019-2025
9 companies · $717 in 2025
The $717 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $34.23 · 2022: $102 · 2023: $1,160 · 2024: $351 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,340 · Travel and Lodging: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.74 |
| Travel and Lodging | $888.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,371.63 | 2022-2025 | Gore Tag Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Cardioform Septal Occluder |
| Boston Scientific Corporation | $544.79 | 2025 | Seismiq Lithotrip_pi, Jetstream Sc, Peripheral Rotalink Plus |
| Medtronic, INC. | $197.78 | 2022-2025 | Valiant Captivia, Venaseal |
| Inari Medical, INC. | $117.07 | 2019 | |
| Pfizer INC. | $102.60 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $88.69 | 2023-2024 | Eliquis, Camzyos |
| Medtronic Vascular, INC. | $34.23 | 2020 | |
| Tactile Systems Technology INC | $31.95 | 2019 | |
| Novo Nordisk INC | $24.87 | 2023 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Swartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.